Perceptive Advisors LLC 13D and 13G filings for Lyra Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-25 4:24 pm Sale | 2025-11-21 | 13D | LYRA THERAPEUTICS INC LYRA | Perceptive Advisors LLC | 0 0.000% | -98,301 (Position Closed) | Filing |
| 2025-11-18 4:14 pm Sale | 2025-11-14 | 13D | LYRA THERAPEUTICS INC LYRA | Perceptive Advisors LLC | 98,301 5.500% | -40,584 (-29.22%) | Filing |
| 2025-11-13 5:05 pm Sale | 2025-11-11 | 13D | LYRA THERAPEUTICS INC LYRA | Perceptive Advisors LLC | 138,885 7.800% | -45,875 (-24.83%) | Filing |
| 2025-11-10 5:07 pm Sale | 2025-11-06 | 13D | LYRA THERAPEUTICS INC LYRA | Perceptive Advisors LLC | 184,760 11.200% | -70,990 (-27.76%) | Filing |